Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
2016 · Clinical Cancer Research · 912 citations
https://doi.org/10.1158/1078-0432.ccr-16-1300
X
Xiaojun Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
480
Papers
11.1K
Citations
39
h-index
149
i10-index
Xiaojun Liu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: CAR-T cell therapy research & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 39, co-authored 408 publications.
ORCID: 0000-0002-5972-907XPapers by this author
worksAffinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
2015 · Cancer Research · 556 citations
https://doi.org/10.1158/0008-5472.can-15-0159
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
2017 · Cancer Immunology Research · 435 citations
https://doi.org/10.1158/2326-6066.cir-17-0189
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
2011 · Human Gene Therapy · 217 citations
https://doi.org/10.1089/hum.2011.070
Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia
2013 · Human Gene Therapy · 108 citations
https://doi.org/10.1089/hum.2013.075
Two Figla homologues have disparate functions during sex differentiation in half-smooth tongue sole (Cynoglossus semilaevis)
2016 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep28219
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat